![John Temperato](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Temperato
Sales & Marketing chez
SALIX PHARMACEUTICALS, LTD.
Profil
John Temperato currently works at uMETHOD Health, Inc., as Chief Executive Officer from 2025, Naia Rare Diseases LLC, as Director from 2020, Salix Pharmaceuticals Ltd., as Senior Vice President-Sales & Managed Markets, and Academy of Managed Care Pharmacy, as Member.
Mr. Temperato also formerly worked at RDD Pharma Ltd., as Chief Executive Officer from 2019 to 2020, 9 Meters Biopharma, Inc., as President, Chief Executive Officer & Director from 2020 to 2023, Atlantic Healthcare Plc, as President & Chief Operating Officer, Melinta Subsidiary Corp., as President & Chief Operating Officer, and Melinta Therapeutics, Inc., as President & Chief Operating Officer.
Mr. Temperato received his undergraduate degree from the University of Bridgeport.
Postes actifs de John Temperato
| Sociétés | Poste | Début |
|---|---|---|
| SALIX PHARMACEUTICALS, LTD. | Sales & Marketing | - |
Academy of Managed Care Pharmacy
 Academy of Managed Care Pharmacy Miscellaneous Commercial ServicesCommercial Services Operates as professional organization representing the interests of pharmacists | Corporate Officer/Principal | - |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Directeur/Membre du Conseil | 01/01/2020 |
uMETHOD Health, Inc.
 uMETHOD Health, Inc. Packaged SoftwareTechnology Services Develops software, which creates personalized therapy recommendation for patients | Directeur Général | 01/03/2025 |
Anciens postes connus de John Temperato
| Sociétés | Poste | Fin |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Directeur Général | 26/05/2023 |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Directeur Général | 01/01/2020 |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Operates as holding company with interest in pharmaceutical | President | - |
| MELINTA THERAPEUTICS, INC. | President | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | President | - |
Formation de John Temperato
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Operates as holding company with interest in pharmaceutical | Health Technology |
uMETHOD Health, Inc.
uMETHOD Health, Inc. Packaged SoftwareTechnology Services Develops software, which creates personalized therapy recommendation for patients | Technology Services |
University of Bridgeport
 University of Bridgeport Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Academy of Managed Care Pharmacy
Academy of Managed Care Pharmacy Miscellaneous Commercial ServicesCommercial Services Operates as professional organization representing the interests of pharmacists | Commercial Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Choisissez Zonebourse 
